NCT06208397Recruiting
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
Noninvasive Evaluation in Diagnosis and Treatment of Histopathological Growth Patterns in Colorectal Liver Metastases Using MR Elastography-based Shear Strain Mapping
Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this study is to investigate the value of MR elastography-based SII as a means of detecting HGP noninvasively in patients with pathology-proven CRLM. MRE will provide a direct measure of tumor-liver adhesion to investigate the relationship between imaging findings and pathophysiological changes in the Liver.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 6 Jan 2024
- Start date
- 24 Dec 2023
- Primary completion date
- 24 Dec 2025
- Lead sponsor
- Shengjing Hospital
- Diseases
- Colorectal cancer
- NCT number
- NCT06208397
What you commit to
- Study type: Observational
- Planned participants: 50
- From 24 Dec 2023 to the primary completion date, 24 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Combined with malignant tumor
- Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who cannot remove dentures, insulin pumps, or contraceptive rings)
Other
- Image quality does not meet the measurement requirements.
- the diameter of CRLM \<1cm
- Combined with other important organ dysfunction
- Patients who do not sign an informed consent
Who the study is looking for
- Diagnosed CRLM
- Pathologic results obtained in surgical patients
- No contraindications for magnetic resonance imaging examination
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Shengjing Hospital Of China Medical University Coordinator of this site? Confirm its status | Shenyang | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.